UBA52 and Parkinson disease: Since the protein-protein interaction of UBA52 with HSP90 and CHIP was observed in pathological conditions, we next investigated the role of UBA52 in HSP90 ubiquitylation in consideration of the observed increased level of HSP90 upon rotenone treatment and probable therapeutic implication of HSP90 in PD [54].